Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients
Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients
Recruiting · NCT06807021 · Registry updated 2026-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, burn, injury, severe cutaneous adverse reaction | Recruiting | Phase 2 / Phase 3 | 2026-09-30 | NCT06807021 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Birch BioMed Inc | 1 |
| Nutrasource Pharmaceutical and Nutraceutical Services, Inc. | 6 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre for Burn Research - Hamilton Health Sciences | Hamilton | Canada | 1 |
| University of Alberta, Division of Plastic Surgery | Edmonton | Canada | 1 |